Track Cronos Group Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Cronos Group Inc. CRON · Stock Open Cronos Group Inc. in new tab

3.38 USD
P/E
21.13
EPS
0.16
P/B
1.16
ROE
6.09
Beta
1.26
Cronos Group Inc. logo

Cronos Group Inc.

🧾 Earnings Recap – Q3 2026

Cronos shares rose 6.0% after the company reported record Q3 net revenue, gross profit and Adjusted EBITDA, alongside strong growth in Israel, Canada and other international markets. The Netherlands acquisition adds a longer-term opportunity, though management expects price compression as suppliers ramp up.

  • Israel net revenue grew 33% year over year, or 19% on a constant-currency basis, marking an 11th consecutive quarterly record.
  • Canadian net revenue reached a record; Cronos brands’ retail sales grew 41% year over year versus 1% industry-wide. Spinach held the top vape position, while SOURZ remained the leading edible brand.
  • Revenue in international markets outside Israel rose sevenfold year over year, from $1.9 million to $13.2 million, led by Germany.
  • Cronos completed its CanAdelaar acquisition in October. Management sees potential in new product formats and operational efficiencies, but says the Dutch market is immature and expects price compression as supply increases.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 25, 2027
P/E21.13
EPS0.16
Book Value2.92
Price to Book1.16
Debt/Equity0.11
% Insiders49.512%
Growth
Revenue Growth0.75%
Earnings Growth-0.45%
Estimates
Forward P/E-84.50
Forward EPS-0.04

DCF valuation

Model fair value for Cronos Group Inc. (CRON)
Result
Sign in to run the valuation for CRON.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Cronos Group Inc. Logo Cronos Group Inc. Analysis (CRON)

Canada Health Care Official Website Stock

Is Cronos Group Inc. a good investment? Cronos Group Inc. (CRON) is currently trading at 3.38 USD.

In terms of valuation, the stock trades at a P/E ratio of 21.13. This valuation is generally in line with the broader market.

Earnings Schedule: Cronos Group Inc. is expected to release its next earnings report on Feb. 25, 2027. The market consensus estimate for Forward EPS is -0.04.

Investor FAQ

Does Cronos Group Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Cronos Group Inc.?

Cronos Group Inc. is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 25, 2027. The company currently has a trailing EPS of 0.16.

Company Profile

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

Exchange Ticker
TOR (Canada) CRON.TO
FRA (Germany) 7CI.F
STU (Germany) 7CI.SG
NMS (United States) CRON
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion